about
Macrophage epoxygenase determines a profibrotic transcriptome signature.Reduced Renal Methylarginine Metabolism Protects against Progressive Kidney Damage.mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype.The MAP kinase pathway coordinates crossover designation with disassembly of synaptonemal complex proteins during meiosis.The PLA2R1-JAK2 pathway upregulates ERRα and its mitochondrial program to exert tumor-suppressive action.Stabilization of the metaphase spindle by Cdc14 is required for recombinational DNA repair.Integrating phosphoproteome and transcriptome reveals new determinants of macrophage multinucleation.Spatiotemporal regulation of Aurora B recruitment ensures release of cohesion during C. elegans oocyte meiosis.The fidelity of synaptonemal complex assembly is regulated by a signaling mechanism that controls early meiotic progression.Temporal dynamics of Wnt-dependent transcriptome reveals an oncogenic Wnt/MYC/ribosome axisErratum: mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotypeUnusual ECD fragmentation attributed to gas-phase helix formation in a conformationally dynamic peptideUtilising ion mobility-mass spectrometry to interrogate macromolecules: Factor H complement control protein modules 10–15 and 19–20 and the DNA-binding core domain of tumour suppressor p53Gas-phase metalloprotein complexes interrogated by ion mobility-mass spectrometryNeuronatin regulates pancreatic β cell insulin content and secretionH4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatidsTRF1 averts chromatin remodelling, recombination and replication dependent-break induced replication at mouse telomeres
P50
Q30273952-ED4B9203-610E-4E84-8610-6632179D1D2FQ30300218-8A570DCE-499A-4FF4-9B76-ECD3A9DEE1AAQ36110081-45D8E294-2041-4FBC-A7D2-B8543BEF13D6Q36723456-794BF986-A593-472A-9040-06451A762D80Q38780995-0E31EB21-016F-4AE1-A6B4-762812061B53Q40643093-95AA2ED9-4C7A-41A3-91B8-78124B27CDBBQ43176423-CA170EC3-DC65-44AA-A10C-9A0FDFF8C232Q52372499-FFF3DA86-2906-469F-8146-C3E4EDFCAB45Q52998112-7A55C0BA-054A-4A91-997F-4D98C39AB6ECQ57289942-17CD6D08-4F17-4B10-9591-91ED9F124057Q57771770-1AFF9FCD-5D1A-4954-9531-85C6A1D63880Q58166068-6A5770C1-F506-4CC0-AC3A-319C786B9016Q58166236-0B19866D-33B8-446A-AEF0-444EA9004E28Q58166268-4A9898D0-34A5-4D79-9C90-5BCA55B1F2B6Q63543938-1B6EEE55-73D4-408F-A548-23CE6D0AC163Q64387751-434A0D29-EF87-4F5E-94C6-B0F4575CF472Q92624119-ED177EB2-0971-4FAD-B8BC-7175B868EE87
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Peter Faull
@ast
Peter Faull
@en
Peter Faull
@es
Peter Faull
@nl
type
label
Peter Faull
@ast
Peter Faull
@en
Peter Faull
@es
Peter Faull
@nl
prefLabel
Peter Faull
@ast
Peter Faull
@en
Peter Faull
@es
Peter Faull
@nl
P108
P106
P1153
26433290800
P21
P31
P496
0000-0001-8491-8086